Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.
October 23, 2023 | 2:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merck & Co's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $135.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Merck & Co. The maintained price target of $135 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100